[ RECIPIENT ENTITY RECORD ]

Oncology Precision Med

VERIFIED NODE ID: 002600 · oncology-precision-med
R TARGET NODE — CAPITAL RECIPIENT
Oncology Precision Med
SPV United States
Recipient Type
SPV
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Oncology Precision Med
Entity Type SPV
Jurisdiction United States
Recipient Intelligence Summary

Oncology Precision Med represents the clinical research and development hub focused on advancing targeted therapies and antibody-drug conjugates for cancer care. This initiative integrates genomic data with pharmaceutical innovation to improve patient outcomes. It is a significant recipient of institutional healthcare capital during biotech expansions.

Capital Influx Log (Transactions)
Date Type Amount
03 Jun 2026 EQUITY $2.5B